Journal of clinical cardiology and cardiovascular therapy最新文献_第9页

A Rare Case of Mumps Myocarditis 罕见的流行性心肌炎1例

Journal of clinical cardiology and cardiovascular therapy Pub Date : 2015-06-10 DOI: 10.17554/j.issn.2309-6861.2014.02.583

B. Marion, L. Benoit, Akodad Mariama, Monnin Valerie, Roubille François

引用次数: 1

Multimodality Imaging of an Isolated Pulmonary Native Valve Infective Endocarditis Due to Staphylococcus Hominis 人型葡萄球菌引起的孤立肺原生瓣膜感染性心内膜炎的多模态成像

Journal of clinical cardiology and cardiovascular therapy Pub Date : 2015-06-10 DOI: 10.17554/j.issn.2309-6861.2014.02.584

G. Malclès, R. Eschalier, C. Dauphin, J. Lusson

引用次数: 0

Colchicine: A Promising Drug in Clinical Translation, A Minireview Focused on Cardiovascular Diseases 秋水仙碱:一种具有临床应用前景的药物——以心血管疾病为中心的综述

Journal of clinical cardiology and cardiovascular therapy Pub Date : 2015-06-10 DOI: 10.17554/j.issn.2309-6861.2015.02.581

B. Lattuca, F. Leclercq, J. Macia, R. Gervasoni, T. Cung, J. Pasquié, F. Massin, S. Cade, F. Cransac, Mariama Akodad, F. Roubille

引用次数: 1

Osteoarthritis and Cardiovascular Diseases: is Meta-Inflammation the Missing Link? 骨关节炎和心血管疾病:中间炎症是缺失的一环吗?

Journal of clinical cardiology and cardiovascular therapy Pub Date : 2015-06-10 DOI: 10.17554/j.issn.2309-6861.2015.02.582

C. Camille, J. Martel-Pelletier, J. Sellam, J. Pelletier, J. Raynauld, F. Roubille

{"title":"Osteoarthritis and Cardiovascular Diseases: is Meta-Inflammation the Missing Link?","authors":"C. Camille, J. Martel-Pelletier, J. Sellam, J. Pelletier, J. Raynauld, F. Roubille","doi":"10.17554/j.issn.2309-6861.2015.02.582","DOIUrl":"https://doi.org/10.17554/j.issn.2309-6861.2015.02.582","url":null,"abstract":"Osteoarthritis (OA) was found associated with atherosclerosis, metabolic syndrome, more cardiovascular diseases (CVD) and higher cardiovascular morbidity and mortality. However, it remains unclear whether these conditions only coexist in ageing patients presenting shared traditional cardiovascular risk factors, including age, obesity and disability-related sedentary lifestyle, or are further interconnected. Interestingly, the accumulation of metabolic syndrome components was associated with the development and progression of knee OA, supporting the concept of metabolic OA. Recent research suggests key roles of meta-inflammation, and adipokines in the pathogenesis of OA, metabolic syndrome and CVD. While leptin may be one cornerstone mediator linking obesity, metabolic syndrome, OA, and CVD, the exact role of adiponectin remains controversial in both CVD and OA as it may exert both pro-inflammatory and anti-inflammatory properties. However, the relationship between adipokines and OA as well as CVD is being uncovered and require further investigation. In any case, if meta-inflammation is truly the pivotal link interconnecting OA, metabolic syndrome, and CVD, managing dyslipidemia, hyperglycemia, hypertension and weight in OA patients may be beneficial not only for cardiovascular reasons but also perhaps to delay OA progression.","PeriodicalId":92802,"journal":{"name":"Journal of clinical cardiology and cardiovascular therapy","volume":"9 1","pages":"315-320"},"PeriodicalIF":0.0,"publicationDate":"2015-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81830955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 2

Ventricular Remodeling after Myocardial Infarct: A Minireview on the Impact of Obstructive Sleep Apnea Syndrome 心肌梗死后心室重构:阻塞性睡眠呼吸暂停综合征影响的综述

Journal of clinical cardiology and cardiovascular therapy Pub Date : 2015-06-10 DOI: 10.17554/j.issn.2309-6861.2015.02.587

K. Solecki, B. Lattuca, F. Leclercq, R. Gervasoni, J. Macia, T. Cung, F. Cransac, S. Cade, J. Davy, Y. Dauvilliers, F. Roubille

{"title":"Ventricular Remodeling after Myocardial Infarct: A Minireview on the Impact of Obstructive Sleep Apnea Syndrome","authors":"K. Solecki, B. Lattuca, F. Leclercq, R. Gervasoni, J. Macia, T. Cung, F. Cransac, S. Cade, J. Davy, Y. Dauvilliers, F. Roubille","doi":"10.17554/j.issn.2309-6861.2015.02.587","DOIUrl":"https://doi.org/10.17554/j.issn.2309-6861.2015.02.587","url":null,"abstract":"Obstructive sleep apnoea (OSA) is recognized as an important cardiovascular risk factor and is intricate with coronary disease. OSA could be involved in worsening the cardiac remodeling following the acute myocardial infarction (AMI). Cardiac remodeling is an important determinant of the clinical outcome of heart failure and is linked to disease progression and poor prognosis. The aims of this minireview are to address the frequency reported in the literature of OSA in patients with AMI and to summarize the main mechanisms of cardiac remodeling by OSA and its consequences on cardiovascular system. In addition, we aim to identify new strategies in the management of AMI. OSA is frequent in patients with AMI. OSA may have a role in cardiac remodeling after AMI and especially in relationship with the increased sensitivity of the reperfused tissue to all underlying mechanisms: a complex interplay of mechanical or haemodynamic factors, reactive oxygen species balance, sympathetic nerve activity, endothelial dysfunction, proinflammatory factors and coagulation abnormalities. Continuous positive airway pressure CPAP might represent a non pharmalogical treatment in addition to the global management of patients with AMI.","PeriodicalId":92802,"journal":{"name":"Journal of clinical cardiology and cardiovascular therapy","volume":"51 Suppl 1 1","pages":"321-328"},"PeriodicalIF":0.0,"publicationDate":"2015-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91007832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Cardiac Resynchronization Therapy in Heart Failure: Rationale, Results, Indications, Limits and Perspectives 心力衰竭的心脏再同步化治疗:基本原理，结果，适应症，限制和观点

Journal of clinical cardiology and cardiovascular therapy Pub Date : 2014-07-10 DOI: 10.17352/2455-2976.000004

A. Mazza, S. Valsecchi, U. Riva, M. G. Bendini, M. Leggio

{"title":"Cardiac Resynchronization Therapy in Heart Failure: Rationale, Results, Indications, Limits and Perspectives","authors":"A. Mazza, S. Valsecchi, U. Riva, M. G. Bendini, M. Leggio","doi":"10.17352/2455-2976.000004","DOIUrl":"https://doi.org/10.17352/2455-2976.000004","url":null,"abstract":"Heart Failure is the result of heterogeneous structural heart diseases, especially ischemic disease, and is becoming increasingly common in all Western countries. Many patients continue to be symptomatic in spite of progress in pharmacological therapy, and the risk of mortality remains high in the most advanced functional classes. Cardiac resynchronization therapy can be used as a therapeutic strategy for alleviating symptoms and reducing mortality in a considerable percentage of patients with heart failure.Cardiac resynchronization therapy provides both immediate and medium/long-term results. The immediate results are the reduced QRS duration, the synchrony restoration between the ventricles and between the lateral and septal walls of the left ventricle, the reduced mitral regurgitation and the increased stroke volume. In the medium/long term, left ventricular reverse remodeling occurs and left ventricular ejection fraction is increased. Several trials have documented both increased functional capacity and improvements in quality of life and New York Heart Association class. Moreover, cardiac resynchronization therapy has been seen to reduce HF hospitalizations and mortality and the total number of days of hospitalization. In order to reduce the percentage of non-responders to cardiac resynchronization therapy, it is necessary to optimize the prognostic stratification of candidates for implantation through multi-parameter evaluations and to ensure correct device programming with periodic updates which are widely recommended but not so often performed. Whether indications should be extended will need to be evaluated in view of the known complications mainly associated with lead implantation.","PeriodicalId":92802,"journal":{"name":"Journal of clinical cardiology and cardiovascular therapy","volume":"16 1","pages":"121-126"},"PeriodicalIF":0.0,"publicationDate":"2014-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75349722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0